Related Experiment Video
Updated: Jun 13, 2025
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
25.7K
Strategies for Cardiovascular Disease Prevention in Type 1 Diabetes: A Comprehensive Review
Abhinav Ahuja1, Sachin Agrawal1, Sourya Acharya1
1Internal Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Cureus
|September 9, 2024
Summary
Preventing cardiovascular disease (CVD) in type 1 diabetes (T1D) requires managing hyperglycemia, hypertension, and dyslipidemia through lifestyle changes and medications. Integrated care and emerging therapies are crucial for improving long-term outcomes.
Area of Science:
- Endocrinology
- Cardiology
- Public Health
Background:
- Cardiovascular disease (CVD) is a major cause of death in type 1 diabetes (T1D).
- T1D accelerates atherosclerosis through hyperglycemia, hypertension, dyslipidemia, and inflammation.
- Effective CVD prevention strategies are urgently needed for T1D patients.
Purpose of the Study:
- To review current evidence and strategies for preventing CVD in individuals with T1D.
- To explore pathophysiological links, risk factors, and management approaches for CVD in T1D.
- To identify emerging therapies and future research directions in this field.
Main Methods:
- Comprehensive literature review of pathophysiological mechanisms, epidemiology, and risk factors.
- Evaluation of lifestyle modifications (diet, exercise, smoking cessation).
- Analysis of pharmacological interventions (insulin, antihypertensives, lipid-lowering, antiplatelet agents).
Main Results:
- Chronic hyperglycemia, hypertension, dyslipidemia, and inflammation are key CVD drivers in T1D.
- Lifestyle modifications and pharmacological treatments significantly reduce CVD risk.
- Integrated care, technology, and personalized medicine show promise for enhanced prevention.
Conclusions:
- A multifaceted approach combining lifestyle, pharmacotherapy, and integrated care is essential for CVD prevention in T1D.
- Addressing challenges like adherence and healthcare access is critical for implementation.
- Continued research into novel therapies and personalized strategies is vital for improving cardiovascular outcomes.
Keywords:
cardiovascular disease preventionintegrated care modelslifestyle modificationspharmacological interventionsrisk assessmenttype 1 diabetesMore Related Videos
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
245
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
245
01:22Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
01:22Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
01:36Carbohydrate Metabolism
10.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K
01:15Diabetes: Symptoms, Diagnosis, and Complications
520
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
520
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
183
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
183